USA Financial Formulas’s Expedia Group EXPE Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q2
$44.5K Buy
174
+172
+8,600% +$40.9K 0.01% 294
2026
Q1
$462 Hold
2
﹤0.01% 394
2025
Q4
$567 Buy
+2
New +$494 ﹤0.01% 356
2025
Q2
Sell
-6,096
Closed -$1.02M 279
2025
Q1
$1.02M Buy
+6,096
New +$1.11M 0.17% 53
2022
Q2
Sell
-377
Closed -$74K 368
2022
Q1
$74K Buy
+377
New +$70.5K 0.08% 117
2019
Q4
Sell
-22,957
Closed -$3.09M 259
2019
Q3
$3.09M Buy
+22,957
New +$3.03M 1.2% 30
2018
Q4
Sell
-3,851
Closed -$463K 350
2018
Q3
$463K Buy
+3,851
New +$500K 0.12% 128
2017
Q4
Sell
-21,071
Closed -$3.03M 288
2017
Q3
$3.03M Buy
+21,071
New +$3.12M 0.72% 68
2016
Q1
Sell
-37,245
Closed -$4.63M 88
2015
Q4
$4.63M Buy
37,245
+7,730
+26% +$979K 1.87% 16
2015
Q3
$3.47M Buy
+29,515
New +$3.4M 2.25% 12
2015
Q1
Sell
-32,718
Closed -$2.79M 201
2014
Q4
$2.79M Buy
+32,718
New +$2.77M 0.96% 23

Other funds holding EXPE

USA Financial Formulas's EXPE Position: Q2 2026 in Review

USA Financial Formulas increased its Expedia Group (EXPE) stake by 8,600% in Q2 2026, buying an estimated $40.9K and bringing the position to 174 shares worth $44.5K. The position accounts for 0.01% of the portfolio, ranked #294.

USA Financial Formulas first reported a position in EXPE in Q4 2014 and has held it in 11 quarters since. The position peaked at $4.63M in Q4 2015. 1,125 funds tracked by Wall St. Rank hold EXPE as of Q2 2026.

  • USA Financial Formulas held 174 shares of Expedia Group worth $44.5K as of Q2 2026.
  • USA Financial Formulas bought 172 Expedia Group shares in Q2 2026, an estimated $40.9K.
  • Expedia Group made up 0.01% of USA Financial Formulas's portfolio in Q2 2026, its #294 holding.
  • USA Financial Formulas first reported a position in Expedia Group in Q4 2014 and has held it in 11 quarters since.
  • USA Financial Formulas's Expedia Group position peaked at $4.63M in Q4 2015.
  • 1,125 funds tracked by Wall St. Rank held Expedia Group as of Q2 2026.

Based on USA Financial Formulas's 13F filing for Q2 2026, filed 4 Aug 2026.